Monte Rosa Therapeutics, Inc. Property, Plant and Equipment, Gross
Monte Rosa Therapeutics, Inc. (GLUE) had Property, Plant and Equipment, Gross of $61.48 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $61.48M.
- 2026-03-31: Property, Plant and Equipment, Gross $58.05M.
- 2025-12-31: Property, Plant and Equipment, Gross $53.60M.
- 2025-09-30: Property, Plant and Equipment, Gross $53.12M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $61.48M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $58.05M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $53.60M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $53.12M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $52.48M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $50.64M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $49.85M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $49.75M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $49.45M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $48.18M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $46.05M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $45.39M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $43.90M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $46.05M 10-Q · filed 2024-05-09 | $40.67M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $33.33M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $24.56M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $19.37M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $16.68M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $15.03M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $13.70M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $10.27M 10-Q · filed 2021-08-12 | |
| 2020-12-31 | $5.23M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |